Cargando…

PET imaging during hypoglycaemia to study adipose tissue metabolism

BACKGROUND: Disturbances in adipose tissue glucose uptake may play a role in the pathogenesis of type 2 diabetes, yet its examination by 2‐deoxy‐2‐[(18)F]fluorodeoxyglucose ([(18)F]FDG) PET/CT is challenged by relatively low uptake kinetics. We tested the hypothesis that performing [(18)F]FDG PET/CT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boss, Marti, Rooijackers, Hanne M. M., Buitinga, Mijke, Janssen, Marcel J. R., Arens, Anne I. J., de Geus‐Oei, Lioe‐Fee, Salm, Liesbeth P., de Galan, Bastiaan E., Gotthardt, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618104/ https://www.ncbi.nlm.nih.gov/pubmed/31002171 http://dx.doi.org/10.1111/eci.13120

Ejemplares similares

Predictive and prognostic value of FDG-PET
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2008)

PET-Based Human Dosimetry of (68)Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
por: Boss, Marti, et al.
Publicado: (2020)

FDG-PET/CT based response-adapted treatment
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2012)

Editorial on Special Issue “Quantitative PET and SPECT”
por: van Velden, Floris H. P., et al.
Publicado: (2022)

Importance of beta cell mass for glycaemic control in people with type 1 diabetes
por: Jansen, Theodorus J. P., et al.
Publicado: (2022)

Methodological considerations in quantification of oncological FDG PET studies
por: Vriens, Dennis, et al.
Publicado: (2009)

PET/CT in Patients with Breast Cancer Treated with Immunotherapy
por: Vaz, Sofia C., et al.
Publicado: (2023)

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma
por: Gilles, Rozemarie, et al.
Publicado: (2011)

Optimal respiratory-gated [(18)F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma
por: Smeets, Esther M. M., et al.
Publicado: (2019)

Elevated brain glutamate levels in type 1 diabetes: correlations with glycaemic control and age of disease onset but not with hypoglycaemia awareness status
por: Wiegers, Evita C., et al.
Publicado: (2019)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

Exendin‐4 analogs in insulinoma theranostics
por: Jansen, Tom.J.P., et al.
Publicado: (2019)

Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
por: Boss, Marti, et al.
Publicado: (2020)

(68)Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
por: Boss, Marti, et al.
Publicado: (2022)

Adding the temporal domain to PET radiomic features
por: Noortman, Wyanne A., et al.
Publicado: (2020)

FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Detection and quantification of beta cells by PET imaging: why clinical implementation has never been closer
por: Gotthardt, Martin, et al.
Publicado: (2018)

Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [(18)F]-FDOPA PET/CT study
por: Schalbroeck, Rik, et al.
Publicado: (2021)

Investigating the potential added value of [(18)F]FDG-PET/CT in long COVID patients with persistent symptoms: a proof of concept study
por: Chen, Linda L., et al.
Publicado: (2023)

Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[(18)F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
por: van der Bruggen, Wouter, et al.
Publicado: (2021)

Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
por: Boss, Marti, et al.
Publicado: (2020)

Clinical impact of artifactual hypoglycaemia and its diagnosis at the bedside
por: Drenthen, Linda C. A., et al.
Publicado: (2019)

Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring (18)F-FDG-PET/CT
por: Meijer, Tineke W.H., et al.
Publicado: (2018)

[(18)F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas
por: Noortman, Wyanne A., et al.
Publicado: (2022)

Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on the inflammatory profile of people with type 1 diabetes
por: Ali, Namam, et al.
Publicado: (2020)

Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas
por: Kleiburg, Fleur, et al.
Publicado: (2023)

Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2022)

The diagnostic value of (18)F–FDG-PET/CT and MRI in suspected vertebral osteomyelitis – a prospective study
por: Kouijzer, Ilse J. E., et al.
Publicado: (2017)

(18)F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) – A prospective externally validated study
por: Carvalho, Sara, et al.
Publicado: (2018)

Ablation margin quantification after thermal ablation of malignant liver tumors: How to optimize the procedure? A systematic review of the available evidence
por: Hendriks, Pim, et al.
Publicado: (2023)

[(18)F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Effect of short‐term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes
por: van Meijel, Lian A., et al.
Publicado: (2021)

Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma
por: Poels, Thomas T., et al.
Publicado: (2021)

The current role of nuclear medicine in breast cancer
por: Vaz, Sofia C., et al.
Publicado: (2023)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients
por: Govaert, Stephanie LA, et al.
Publicado: (2012)

Prognostic Value of Quantitative [(18)F]FDG-PET Features in Patients with Metastases from Soft Tissue Sarcoma
por: Kalisvaart, Gijsbert M., et al.
Publicado: (2021)

Nanocarriers as a Tool for the Treatment of Colorectal Cancer
por: C. de S. L. Oliveira, Ana Luiza, et al.
Publicado: (2021)

A comparison of the diagnostic value of MRI and (18)F-FDG-PET/CT in suspected spondylodiscitis
por: Smids, Carolijn, et al.
Publicado: (2016)

Cold-induced dishabituation in rodents exposed to recurrent hypoglycaemia
por: Vickneson, Keeran, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_skqanvjr45ouq51eaibest9ufk